The quality of life after transnasal microsurgical and endoscopic resection of nonfunctioning pituitary adenoma

Comparison of Sinonasal Outcomes in Patients Undergoing Uni-nostril and Bi-nostril Endoscopic Trans-sphenoidal Excision of Pituitary Adenomas: A Prospective Study

“…Instruments that have been utilized for assessment of QoL following endoscopic pituitary surgery include Anterior Skull Base Nasal Inventory-12 (ASK Nasal-12), 22,41 SNOT 22, 14,[18][19][20]41 SNOT 20, 13 VAS, 13 SF-36, 42 and WHO-QoL BREF. 43 The ASK-12 is a site specific 12 question inventory which focuses on sinonasal morbidity and evaluates all likely This article is protected by copyright. All rights reserved.…”

“…Instruments that have been utilized for assessment of QoL following endoscopic pituitary surgery include ASK-12, 22,41 SNOT-22, 14,[18][19][20]41 SNOT-20, 13 VAS (visual analogue scale), 13 SF-36, 42 and WHO-QoL BREF. 43 The ASK-12 is a site-specific 12-question inventory which focuses on sinonasal morbidity and evaluates all likely symptoms related to impaired nasal function, taste, airway, tearing, and ear function. This instrument is also specific for postoperative skull base surgery unlike the SNOT-22, which is more suited to postoperative assessment of endoscopic sinus surgery and the Nasal Obstruction Symptom Evaluation (NOSE) inventory which is more suited to septal surgery.…”

“…Also, most of the studies are focused on the bi-nostril technique. 13,16,19,30,34,37,38,43,[52][53][54][55][56] Finally, the studies report on patients undergoing both the extended and standard versions of the surgery. Thus, the indications for the endoscopic surgery include both pituitary adenomas and other pathologies such as craniopharyngiomas and meningiomas for which an extended approach is used and typically the resection of nasal mucosa is more extensive.…”

Progressive resistance exercise in patients with pituitary adenoma: it does work

“…The inclusion criteria of patients were as following: (1) Preoperative disease was diagnosed as sellar area mass, sellar tumor or pituitary adenoma, and postoperative pathology report was pituitary adenoma; (2) The surgical method was lesions caused by transnasal sinus approach resection; (3) The age of the patient was18-65 years; (4) The patient had informed consent and voluntarily participated in the study and accepted follow-up. The exclusion criteria for patients were as following: (1) Those who had undergone surgery again within 12 weeks after surgery; (2) Those who had severe cardiopulmonary insufficiency and could not cooperate with exercise; (3) Disabled legs or knee joint and lumbar spine lesions could not tolerate muscle strength Those who measure; (4) Those who had metal grafts in their bodies that affect the accuracy of body composition measurement; (5) Those who disagreed to participant or required withdrawal during the research process.…”

“…Epidemiologic studies [2,3] show that pituitary adenomas are increasing in incidence (between 3.9 and 7.4 cases per 100,000 per year) and prevalence (76 to 116 cases per 100,000 population) in the general population (approximately 1 case per 1000 of the general population). Although most of them are benign, they can cause headaches, loss of vision, infertility, acromegaly and other symptoms [4,5]. Even after surgery, m any patients suffer from long-term discomfort symptoms, among which fatigue is the most common [6].…”